Evidence map›Paper›PMID 25343113›Full record

ReviewIntractable & rare diseases research2013

Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.

Lin Mei, Peipei Song, Norihiro Kokudo, Lingzhong Xu, Wei Tang

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Intractable & rare diseases research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Progress and Prospects of Newborn Screening in China.International journal of neonatal screening · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lin MeiDepartment of Health Care Management and Maternal and Child Health, Shandong University, Ji'nan, Shandong, China; ; Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Peipei SongDepartment of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Norihiro KokudoDepartment of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Lingzhong XuDepartment of Health Care Management and Maternal and Child Health, Shandong University, Ji'nan, Shandong, China;
Wei TangDepartment of Health Care Management and Maternal and Child Health, Shandong University, Ji'nan, Shandong, China; ; Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shandong Maternal and Child Health Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenylketonuria (PKU) is a treat-able and prevent-able inborn error of metabolism which leads to severe mental retardation and neurobehavioral abnormalities. A screening program, especially for early detection, combined with a Phe-restricted therapeutic diet can help to control the process of PKU of most patients. The China government has put more emphasis on newborn screening and treatment against PKU, yet by comparing the situation of newborn screening and treatment against PKU in China and the relatively developed countries - United States, United Kingdom and Japan, the newborn screening and treatment against PKU in China is relatively weak and many deficiencies are found. More studies concerning multi-stage target blood Phe concentration criteria, a policy that requires newborn screening has to be taken, better financial support for newborn screening, publicity for newborn screening, and national guidelines for treatment of PKU may be prospects in China and may provide some support for better development of newborn screening and treatment against PKU in China.

Indexed as

guidelinesnewborn screeningPhenylketonuria (PKU)policytreatment

Identifiers

PMID25343113
PMCPMC4204557
OpenAlexW2028512545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.